Home » Topics » BioWorld Science

BioWorld Science
RSS

Valneva initiates further phase III study of chikungunya vaccine candidate VLA-1553

Feb. 22, 2021

MMP-14 is a potential marker of vestibular schwannomas

Feb. 22, 2021

First-in-human data from SAD and MAD studies of LTI-291 in healthy volunteers

Feb. 22, 2021

Insmed reports phase I safety and PK data for treprostinil palmitil inhalation powder

Feb. 22, 2021

Positive topline data from pivotal phase III SKYLIGHT 1 and SKYLIGHT 2 studies of fezolinetant

Feb. 22, 2021

Zebrafish used to model perivascular glioblastoma multiforme invasion

Feb. 19, 2021

CHI3L1 is a risk marker for delirium in older patients undergoing surgery

Feb. 19, 2021

Dopamine progenitor cell product MSK-DA01 ameliorates Parkinsonian deficits in animal model

Feb. 19, 2021

Orinove initiates phase Ib trial of oral ORIN-1001 in IPF

Feb. 19, 2021

Rocket begins phase I study of RP-L401 in infantile malignant osteopetrosis

Feb. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...